Sage Journals: Discover world-class research

Abstract

Transient receptor potential vanilloid 1 (TRPV1) activation by capsaicin binding increased intracellular calcium influx and stimulated adipocyte-to-adipocyte communication, leading to lipolysis. Generally, enhancement of π-stacking capabilities improves certain binding interactions. Notably, nitroarenes exhibit strong binding interactions with aromatic amino acid side chains in proteins. New capsaicinoid analogs were designed by substitution of the OCH₃ group with a nitrogen dioxide (NO₂) group on the vanillyl ring to investigate how π-stacking interactions in capsaicinoid analogs contribute to lipolysis. Capsaicinoid analogs, nitro capsaicin (5), and nitro dihydrocapsaicin (6) were prepared in moderate yields via coupling of a nitroaromatic amine salt and fatty acids. Oil Red O staining and triglyceride assays with 10 µM loading of capsaicin (CAP), dihydrocapsaicin (DHC), 5, and 6 were performed to investigate their effect on lipolysis in 3T3-L1 adipocytes. Both assay results indicated that 5 and 6 decreased lipid accumulation by 13.6% and 14.7%, respectively, and significantly reduced triglyceride content by 26.9% and 28.4%, respectively, in comparison with the control experiment. Furthermore, the decrease in triglyceride content observed in response to nitroarene capsaicinoid analogs was approximately 2-folds higher than that of CAP and DHC. These results arose from the NO₂ group augmented π-π stacking with Tyr511 and the attractive charge interaction with Glu570 affecting binding interactions with TRPV1 receptors.

Keywords

nitroarene capsaicinoid analogs alkaloids 3T3-L1 adipocyte Oil Red O staining triglyceride lipolysis

The increasing number of overweight individuals has become a major global concern for maintaining healthy lifestyles. In 2016, in excess of 1.9 billion adults were overweight, with at least 650 million of them being obese, and the numbers continue to increase worldwide.¹ Moreover, obesity is one of the chief factors leading to noncommunicable diseases,² such as hyperglycemia,³ hypertension,⁴ coronary heart disease,⁵ ischemic stroke,⁶ respiratory complications,⁷ and atherosclerosis.⁸ Previous studies have revealed that excess weight and obesity are the result of energy disproportion between consumption and utilization of calories in the body, which leads to inordinate fat storage^9
-11 and increasing the numbers, size, and mass of adipocytes.¹²

Generally, adipocytes, the most prevalent cells among adipose tissues, control anabolism, by transforming energy intake into triglycerides, as well as catabolism, by converting triglycerides to free fatty acids.^13

-16 Furthermore, adipocytes regulate lipid mobilization and distribution in the body.¹⁷ Therefore, they play a key role in energy balance and body weight management.¹⁸ Currently, functional food from natural sources is being utilized as an alternative approach for weight management. For example, coffee, tea, garlic, and soybeans have been demonstrated as being beneficial for ameliorating the energy balance in overweight people.¹⁹ Presently, several bioactive compounds are employed as ingredients in supplementary food for weight control, including resveratrol from grapes,²⁰ quercetin from onions,²¹ genistein from soy,²² 6-shogaol from ginger,²³ and piperine from pepper.²⁴ Capsaicin (CAP) from chilies, which is generally used as a flavor ingredient in spicy foods, has also found use in the context of weight control.²⁵ Furthermore, the beneficial role of CAP has been established for the treatment and prevention of several diseases, such as cardiovascular,²⁶ gastrointestinal,²⁷ and Alzheimer’s,²⁸ as well as cancers.²⁹ Moreover, CAP is well known as a treatment for inflammatory and pain symptoms, such as those associated with rheumatoid arthritis, posthepatic neuralgia, and osteoarthritis.³⁰

The mode of action of CAP involves the transient receptor potential vanilloid 1 (TRPV1) receptors. Based on the structure-activity relationships of CAP and TRPV1, CAP is generally divided into 3 sections (Figure 1): the head section (vanillyl residue), neck section (amide bond), and tail section (hydrocarbon chain). Previously, computational calculations of CAP-TRPV1 binding interactions had revealed that the vanillyl moiety and amide bond are involved through hydrogen bonding. Moreover, the unsaturated hydrocarbon chain displays nonspecific Van der Waals interactions with TRPV1 receptors.³¹ Recently, further evidence has suggested that TRPV1 activation from CAP increases intracellular calcium influx, which then stimulates adipocyte-to-adipocyte communication, leading to lipolysis.³² Enhancement of binding interactions between ligands and TRPV1 receptors has been achieved via various approaches, such as increasing the number of hydrogen bonding sites,^33

-39 alteration of the amide bond,^40

-43 and structural modification of the tail section.^44

-47

Figure 1

Segmentation of capsaicin (CAP) into 3 sections: (1) head section (vanillyl residue), (2) neck section (amide bond), and (3) tail section (hydrocarbon chain). Chemical structures of naturally occurring capsaicinoids: CAP, dihydrocapsaicin (DHC), and synthetic nitro capsaicinoid analogs: nitro capsaicin (5) and nitro dihydrocapsaicin (6).

Additionally, nondestructive and noncovalent π-stacking interactions are an important phenomenon that has been extensively investigated for application in chemistry and molecular biology, especially regarding binding interactions in enzymes and receptors.⁴⁸ Computational calculations have established that the attachment of nitrogen dioxide (NO₂) groups on aromatic rings results in strong π-stacking interactions, particularly with tryptophan, tyrosine, phenylalanine, and histidine, which consequently significantly promotes binding interactions with proteins.⁴⁹

Structurally, the vanillyl residue represents a crucial pharmacophore that contributes to TRPV1 binding. Removal of the OH group, which acts as a hydrogen bond donor on the vanillyl residue, clearly diminishes binding interactions, thereby reducing TRPV1 activation.⁵⁰ To avoid alteration of the OH group while promoting binding affinity with TRPV1 receptors, an appropriate approach for the modification of CAP in order to increase lipolysis involves the adjustment of π-stacking interactions of the vanillyl residue. The NO₂ group was therefore chosen to substitute the OCH₃ group on the vanillyl residue, as its introduction onto the aromatic ring can be accomplished employing relatively straightforward chemistry. It should be noted that a CAP-like analog containing this modification of the aromatic region, as well as other structural modifications, has been shown previously to bind to the TRPV1.³³ To explore this hypothesis, nitro capsaicin (5) and nitro dihydrocapsaicin (6) (Figure 1) were synthesized using standard peptide coupling between a nitroaromatic amine salt and the corresponding fatty acids. Next, lipolysis in 3T3-L1 adipocytes exposed to CAP, dihydrocapsaicin (DHC), 5, and 6 in 3T3-L1 adipocytes was investigated.

The construction of 5 and 6 was inspired by the biosynthesis of CAP, which involves fatty acid derivatives, vanillyl amine, and the action of the key enzyme, CAP synthase, which connects the residues via amide bond formation.⁵¹ Likewise, the preparation of capsiate, an unstable capsinoid, has been achieved via an analogous approach by coupling a fatty acid and vanillyl alcohol with lipase.⁵² In this investigation, we performed the synthesis in 2 parts: (1) the preparation of nitrobenzylamine salt 2 and (2) the coupling reaction between the nitrobenzylamine salt 2 and an appropriate fatty acid 3 or 4 using N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC.HCl) as the coupling agent (Scheme 1).

First, commercially available 4-hydroxybenzaldehyde (1) underwent nitration with nitric acid and sulfuric acid under reflux for 30 minutes to deliver the NO₂ group at the C-3 position on the ring. Without purification, the reaction mixtures were then reduced with ammonium formate at 180 °C for 4 hours.^53,54 Under these conditions, the aldehyde underwent selective reductive amination to give the requisite amine in moderate yield, while the NO₂ group remained intact. Subsequently, the reaction mixture was acidified with HCl to give nitrobenzylamine salt 2 with an overall yield of 68% over the 3 steps, after recrystallization from absolute ethanol. The infrared (IR) signals for 2 appearing at 1534 and 1332 cm⁻¹ indicated N-O stretching, thus confirming the presence of the NO₂ group on the aromatic ring.

Next, 5 and 6 were prepared via standard amide coupling between the nitrobenzylamine salt 2 and either (E)-8-methyl-6-noneoic acid (3) or 8-methylnonanoic acid (4), respectively. Both 3 and 4 were readily synthesized according to a literature procedure^53,55 and obtained after high-performance liquid chromatography (HPLC) purification as light yellow oils. The corresponding fatty acids 3 or 4 were activated with EDC.HCl and 1-hydroxy benzotriazole (HOBt), while the nitrobenzylamine salt 2 was treated with triethylamine. The 2 solutions were then mixed under a nitrogen atmosphere and reacted for 6 hours. The purification was achieved by column chromatography using ethyl acetate (EtOAc)/hexane 1:1 as eluent, followed by further purification by HPLC with acetonitrile:water:acetic acid (1:1:0.1) as the mobile phase to afford the target compounds 5 and 6 in high purity. Under these unoptimized conditions, the capsaicinoid analogs 5 and 6 were obtained in 47% and 50% yields, respectively.

Scheme 1

Synthetic route of preparation of capsaicinoid analogs 5 and 6 via amide coupling between an aromatic amine and fatty acids.

A previous report⁵⁵ had established that CAP, the most pungent of the capsaicinoid analogs, induced apoptosis of 3T3-L1 adipocytes in the concentration range from 50 to 250 µM after 24 hour exposure. Unlike CAP, the nitroarene capsaicinoid analogs are less pungent, which was evident during the synthesis. Therefore, CAP was selected for the initial screen to establish a suitable concentration for use in the biological studies. With the mentioned criteria, we explored the appropriate concentration of CAP using its cytotoxicity with differentiated 3T3-L1 adipocytes, as determined using 3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyltetrazolium bromide (MTT) assay. Differentiated 3T3-L1 adipocytes were tested with various concentrations of CAP (5, 10, 25, 50, and 100 µM) for 24 hours. The results shown in Figure 2(A) demonstrate that concentrations of CAP under 10 µM exhibited no significant cytotoxicity to differentiated 3T3-L1 adipocytes in comparison with the vehicle control (no CAP treatment). In order to observe a distinct change in biological activities, 10 µM CAP, DHC, 5, and 6 was deemed an optimal concentration for cell viability, lipid accumulation, and triglyceride studies. A 10 µM concentration of CAP provides maximum activation of TRPV1 receptors after 24 hours of exposure, as previously reported.³¹ As can be seen in Figure 2(B), the cell viabilities of differentiated 3T3-L1 adipocytes treated with CAP, DHC, 5, and 6 exceeded 96% in comparison with cell viability in the control group, and there were no significant differences in cell viability between cells treated with CAP, DHC, 5, and 6.

Figure 2

(A) Effect of CAP at 5 different concentrations (5, 10, 25, 50, and 100 µM) on cell viability. (B) Effect of CAP, DHC, 5, and 6 at 10 µM on cell viability. Differentiated 3T3-L1 adipocytes were treated for 24 hours. The cell viability was quantified and compared with control by measurement using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay at an absorbance of 595 nm. Data are expressed as mean ± SE from 3 independent experiments. *P < 0.05 versus the vehicle control. CAP, capsaicin; DHC, dihydrocapsaicin.

Oil Red O staining of differentiated 3T3-L1 adipocytes treated with 10 μM CAP, DHC, 5, and 6 was performed to observe lipid accumulation. After 24 hours, the results revealed that after treating the cells with 5 and 6 for 24 hours, lipid accumulation had significantly decreased in comparison to the dimethylsulfoxide (DMSO)-treated control cells. The observed decreases in lipid accumulation were 13.6 and 14.7 % for compounds 5 and 6, respectively, as shown in Figure 3. On the other hand, CAP and DHC reduced lipid accumulation by only 5.6 and 8.1 %, respectively, compared with the DMSO-treated control cells. Structurally, CAP and 5, as well as DHC and 6, are isosteres in the tail region and it appears that the NO₂ group on the aromatic ring leads to significantly reduced lipid accumulation elicited by 5, in comparison with the corresponding parent structure (CAP). The analogs result was obtained for 6 and its parent structure (DHC).

Figure 3

Effect of CAP, DHC, 5, and 6 on the lipid content of differentiated 3T3-L1 adipocytes. Differentiated 3T3-L1 adipocytes were incubated with CAP, DHC, 5, and 6 at 10 µM for 24 hours. The cells were stained with Oil Red O and quantified by measuring absorbances at 500 nm. Data are expressed as mean ± SE from 3 independent experiments. ^* P < 0.05 versus the respective parent compounds. CAP, capsaicin; DHC, dihydrocapsaicin.

In addition to lipid accumulation, intracellular lipolysis metabolism of differentiated 3T3-L1 adipocytes was examined by measuring triglyceride levels, using the Cayman triglyceride assay kit. Differentiated 3T3-L1 adipocytes were treated with CAP, DHC, 5, and 6 for 48 hours to evaluate and compare their lipolysis properties. The results indicated that differentiated 3T3-L1 adipocytes treated with 10 µM CAP, DHC, 5, and 6 exhibited significant decreases in triglyceride content. The observed decreases in triglyceride content were 12.7%, 11.5%, 26.9%, and 28.4% for CAP, DHC, 5, and 6, respectively, as compared with the control (Table 1). Analogous to the results of lipid accumulation, both 5 and 6 revealed an approximately 2-fold higher reduction in triglyceride content when compared with that of their corresponding parent structures. The results of both lipid accumulation and triglyceride content experiments emphasize the effect of the NO₂ group and its significant contribution to lipolysis in differentiated 3T3-L1 adipocytes.

Table 1

Effect of CAP, DHC, 5, and 6 on the Level of Triglyceride With Differentiated 3T3-L1 Adipocytes. Differentiated 3T3-L1 Adipocytes Were Treated With CAP, DHC, 5, and 6 at 10 µm for 48 hours.

Groups	Triglyceride (% of control)
Control	100
CAP	87.3 + 3.4^a
DHC	88.5 + 0.7^a
Nitro capsaicin (5)	73.1 + 2.7^a ^b ^c
Nitro dihydrocapsaicin (6)	71.6 + 2.2^a ^b ^c

Abbreviations: CAP, capsaicin; DHC, dihydrocapsaicin.

All measurements were obtained from at least 3 independent experiments, each of which was performed in triplicate (n = 3). The data are presented as mean ± SE.

^a P < 0.05 versus the control.

^b P <0.05 versus CAP.

^c P < 0.05 versus DHC.

π-Stacking interactions can be manipulated by attenuating hydrophobicity, surface area of substituents, electronegativity, and dipole moment of the participating residues.⁵⁶ The inclusion of a NO₂ group presumably increases the dipole moment on 5 and 6, which contributes to enhanced π-stacking interactions, compared with those in their original parent structure. To observe and compare electron distribution in the aromatic region of the studied compounds, density functional theory was applied. In order to focus on the aromatic region, the calculations were performed with model compounds in which the long-chain hydrocarbon unit was simplified by a CH₃ group. The geometry optimizations, Hessian calculations, and molecular property calculations were conducted at the B3LYP/6-31+G(d) level of theory to locate the equilibrium geometries located on the local minimum with no imaginary frequency. It was found that the calculated dipole moment of the model compound representing the parent structures (CAP and DHC) was equal to 2.09 Debye with a volume of 149.44 cm³/mol and was directed from the aromatic ring to the amide bond. In the case of the model compound representing the novel nitro compounds 5 and 6, the calculated dipole moment was 6.16 Debye with volume 150.51 cm³/mol and the direction of the dipole moment was pointed from the aromatic ring to the methylene group located between the aromatic residue and the amide bond.

The significant increase in the calculated dipole moment in the model compounds bearing a nitro group resulted from the appreciable negative charge of the NO₂ group. The HOMO orbital plot illustrates that the electrons are predominantly localized on the carbon atom of the aromatic ring for both model compounds. However, only the model structure for the nitro-containing compounds 5 and 6 exhibited electrons localized in the methylene carbon and amide bond, as shown in Figure 4. Thus, the model structure for the nitro-containing products displays a more conjugated double bond character, distributing electrons from the aromatic ring to the outer regions. This likely creates a lower π-electron density at the aromatic ring, which is analogous to a previous report.⁵⁷

Figure 4

Calculated molecular structures, dipole moments (blue arrow), and HOMO orbitals of the model compounds representing (A) the parent structures CAP and DHC and (B) the model compound representing the novel nitro compounds 5 and 6 at the B3LYP/6-31 + G(d) level of theory. All of these calculations were made by using the Gaussian09 program package,⁵⁸ and the molecular graphics were drawn in the Gabedit program.⁵⁹ CAP, capsaicin; DHC, dihydrocapsaicin.

Not only were the calculated dipole moment values and predicted electron distribution on the model structure for the nitro-containing compounds 5 and 6 different from the model compound representing the parent structures (CAP and DHC) but also previous work by Walpole and co-workers³³ demonstrated that capsaicinoid analogs containing the aromatic region substituted with a nitro group exhibit binding interactions with TRPV1. Therefore, the binding interactions were then analyzed to confirm how the nitro group affected the π-stacking interactions. Additionally, the predicted binding affinity values were also calculated while binding to the TRPV1 receptor. Due to the widespread use of CAP for several applications as a supplement and functional compound, 5 and CAP were selected first as the representative compounds to observe the difference between them in terms of their binding interactions. To obtain this information, molecular dynamics simulations (for the flexible ligands) were performed using a semi-rigid docking method (using the CHARMm program) to explore the possible binding conformations of the molecules. Then, the energy minimized structures were refined using a grid-based simulated annealing algorithm.

The total number of docking poses for 5 and CAP in the defined vanilloid binding pocket of the TRPV1 receptor were 14 and 19, respectively. The successful binding conformations of 5 and CAP, obtained by molecular docking experiments, in the vanilloid binding site of the TRPV1 receptor, were sorted according to their CDOCKER Interaction Energy values (from higher to lower energy values). The docking poses of 5 and CAP with the highest CDOCKER Interaction Energy scores of −42.96 and −39.94 kcal/mol, respectively, were selected for further energy minimization calculations. Following this, the binding interactions between the receptor and the ligand molecules were analyzed. The superposition of the energy-minimized structures of 5 and CAP and the corresponding key amino acid residues of the TRPV1 receptor that interact with these ligands are shown in Figure 5.

Figure 5

The best docking pose of 5 (red stick) and CAP (yellow stick) in the vanilloid binding site of the TRPV1 receptor. The structures are represented by superposition of docking poses and the corresponding key amino acid residues (red and yellow lines) interacting with the TRPV1 receptor (green and blue ribbon for chain D and B, respectively) are illustrated. CAP, capsaicin; TRPV1, transient receptor potential vanilloid 1.

The overall binding free energies of 5 and CAP were −83.47 and −79.60 kcal/mol, respectively, indicating that the predicted binding affinity value of 5 was higher than that of CAP (in the vanilloid binding pocket of the TRPV1 receptor). Moreover, the nonbonded interaction energy values (the van der Waals and electrostatic energies) calculated for the interaction between the amino acid residues (within 4 Å of 5 and CAP) and the ligands in the binding pocket are −43.33 kcal/mol for CAP and −53.93 kcal/mol for 5. The difference in the nonbonded interaction energies of the ligands arises from the electrostatic energy, potentially originating from the interaction of charges between the nitro group-containing molecule and the nearby amino acid residues. The interactions between the 5 and CAP molecules and the corresponding key amino acid residues of the TRPV1 receptor are shown as 3-dimensional structures and 2-dimensional interaction diagrams in Figure 6.

Figure 6

Molecular docking diagram of (A) CAP and (B) 5 with TRPV1 receptor. The figure depicts the best binding conformations and possible binding modes at the vanilloid binding site of the TRPV1 receptor. The graphical representations of binding interactions are presented as a 3-dimensional structure and 2-dimensional interaction diagrams. CAP, capsaicin; TRPV1, transient receptor potential vanilloid 1.

The amide group of the CAP is in close proximity to the Leu669 and Thr550 amino acid residues of the receptor molecule. However, no interaction between the ligand and the receptor amino acid units was predicted. Moreover, the terminal methylene carbon of the CAP tail interacted with the Phe543 and Met547 receptor residues in the extracellular region of the TRPV1 receptor. At the vanilloid binding pocket of the intracellular region of the TRPV1 receptor, a T-shaped π-π stacking interaction was observed between the Tyr511 residue and the vanilloid ring of the CAP molecule (Figure 6(A)). The calculated interaction values agreed well with the experimentally obtained ones. The results were also consistent with those obtained from previous molecular modeling studies (binding studies between the CAP molecule and the TRPV1 receptor).^31,60
-62

The binding conformation of 5 was similar to that exhibited by the CAP molecule (Figure 6(B)). All residues interact with 5 via the same type of binding interactions (even though no interaction was theoretically predicted). In addition, a well-defined T-shaped π-π stacking interaction was observed between 5 and the aromatic ring of the Tyr551 residue. A higher nonbonding interaction (compared with CAP) was observed between the Tyr511 residue and 5 (Table 2). The result supports the hypothesis that stronger π-π stacking interaction is present inside the binding pocket of the TRPV1 receptor when the binding ligand is 5. This might be explained by the lower π-electron density of the aromatic ring of the nitro-containing molecule. Additionally, an attractive charge interaction between the nitro group and the Glu570 residue is also observed and contributes to the strong binding interaction of 5 when compared with that of CAP.

Table 2

Interaction Energies Per-Residue Within 4 Å of CAP and 5 in the Capsaicin-Binding Pocket of TRPV1 Ion Channel.

Residue	CAP interaction energy (kcal/mol)			5 interaction energy (kcal/mol)
Residue	Total interaction	VDW interaction	Electrostatic interaction	Total interaction	VDW interaction	Electrostatic interaction
TYR511	−5.82	−3.44	−2.38	−6.55	−3.28	−3.27
SER512	1.43	−2.23	3.66	1.64	−0.69	2.33
LEU515	−4.58	−3.27	−1.30	−3.49	−2.90	−0.59
PHE516	1.44	−0.59	2.03	-	-	-
VAL518	−1.83	−0.37	−1.46	-	-	-
PHE522	−0.63	−1.12	0.49	-	-	-
PHE543	−4.44	−2.39	−2.05	−6.21	−2.87	−3.34
ALA546	-	-	-	−1.86	−1.31	−0.55
MET547	−3.72	−4.06	0.34	−3.11	−3.79	0.68
THR550	−3.20	−2.80	−0.40	−4.75	−3.24	−1.51
ASN551	−7.07	−1.79	−5.28	−3.84	−2.25	−1.59
LEU553	−1.41	−1.68	0.27	−1.13	−1.65	0.52
TYR554	−1.43	−1.34	−0.09	−1.15	−1.53	0.38
ARG557	3.88	−0.38	4.26	0.03	−0.58	0.61
ALA566	−0.77	−0.38	−0.39	−0.96	−0.45	−0.51
ILE569	−1.22	−1.38	0.16	−2.81	−2.69	−0.12
GLU570	−8.02	−1.29	−6.73	−8.67	−1.95	−6.72
ILE573	−2.07	−2.22	0.15	−3.18	−2.05	−1.13
PHE587	−1.19	−0.76	−0.43	−1.76	−1.47	−0.29
PHE591	−1.09	−0.39	−0.70	−2.29	−1.12	−1.17
LEU662	-	-	-	−0.42	−0.37	−0.05
ALA665	-	-	-	−1.91	−0.40	−1.50
LEU669	−1.60	−1.46	−0.14	−1.52	−1.82	0.30
Total	−43.33	−33.34	−9.99	−53.93	−36.41	−17.52

Abbreviations: CAP, capsaicin; TRPV1, transient receptor potential vanilloid 1; VDW, Van der Waals.

Conclusions

Herein we demonstrate a facile synthetic route for synthesizing the respective CAP and DHC analogs 5 and 6. The analogs were synthesized via the amide coupling reaction between fatty acids and an aromatic amine using EDC.HCl and HOBt as the coupling reagents. The results from the lipolysis study demonstrated that compared with the cells treated with the parent compounds, those treated with 5 and 6 showed a lesser degree of lipid accumulation and triglyceride contents (in differentiated 3T3-L1 adipocytes).

The introduction of the nitro group in the CAP skeleton had a significant effect on the lipolysis process. The nitro-substituted vanilloid ring could potentially improve the lipolytic activity due to the optimal π-π stacking and attractive charge interactions present between the substituted vanilloid ring and the Tyr511 and Glu570 residues, respectively. This specific interaction could increase the binding affinity and stability.

These preliminary findings suggest that the nitroarene capsaicinoid analogs can be used to reduce the triglyceride levels in cells. They may also help in overcoming obesity. Presently, a comprehensive study on the pungency of the nitroarene capsaicinoid analogs is being carried out. Their potential role as skin irritants is also being explored. These factors must be accounted for before the compounds can be developed as supplements for topical applications.

Experimental

General

CAP, DHC, 4-hydroxybenzaldehyde, MTT, Oil Red O solution, DMSO, and human recombinant insulin were obtained from Sigma-Aldrich (St. Louis, MO, USA); high glucose Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum (FBS), bovine calf serum (BCS), phosphate-buffered saline (PBS), antibiotics (100 unit/mL penicillin and 100 µg/mL streptomycin) from GIBCO (Grand Island, NY, USA); dexamethasone (DEX) and 3-isobutyl-1-methyl xanthine (IBMX) from Merck (Kenilworth, NJ, USA); HOBt from Acros Organic (Geel, Belgium); EDC.HCl from GL Biochem (Shanghai, China); Triton X-100 from VWR international (Radnor, PA, USA); 3T3-L1 preadipocytes (ATCC CL-173) from the American Type Culture Collection (Manassas, VA, USA); and the triglyceride colorimetric assay kit from Cayman Chemical (Ann Arbor, MI, USA). All chemical reagents were used as received from vendors unless otherwise noted.

¹H NMR and ¹³C NMR spectra were recorded on a 400 MHz NMR spectrophotometer (AVANCE, Bruker, Switzerland) in appropriate deuterated solvents. Chemical shifts (δ) are reported in parts per million (ppm) relative to either tetramethylsilane or the residual protonated solvent signal as a reference. Mass spectra were measured in positive ion mode with a high-resolution mass spectrometer (micrOTOF, Bruker, Switzerland) with electrospray ionization using sodium formate for calibration. IR spectra were obtained on a Fourier-transform infrared (FT-IR) spectrophotometer (Model 1600, Perkin Elmer, USA) in the wavenumber range of 4000–400 cm^-1. The absorbance was measured using a microplate reader (Synergy H1 Hybrid Multi-Mode Reader, BioTek, USA).

Synthesis of 4-Hydroxy-3-Nitrobenzylamine Hydrochloride (2)

4-Hydroxybenzaldehyde (1) (1.02 g, 8.19 mmol) was dissolved in 98% sulfuric acid (2 mL) and cooled in an ice bath. The resultant mixture was then added dropwise into a cold nitrating solution (0.41 mL, 9.01 mmol of 98% sulfuric acid and 0.42 mL, 9.02 mmol of 65% nitric acid). The reaction mixture was stirred at room temperature for 30 minutes, poured onto ice, and stirred until a yellow precipitate formed. This was filtered, washed with cold ethanol, and dried in vacuo.

The dried yellow precipitate was reacted with ammonium formate (0.38 g, 5.98 mmol) in a round-bottom flask connected to a sealed reflux apparatus. The reaction mixture was then refluxed at 180 °C for 4 hours, after which time it was cooled to room temperature and conc. HCl (2 mL) was added. The reaction mixture was then refluxed at 100 °C for 1 hour. The mixture was cooled to room temperature and the formed precipitate was collected by filtration, washed with ice-cold absolute ethanol (3 × 5 mL), and recrystallized from absolute ethanol to give compound 2 (0.86 g, 51% yield).

Compound 2, light-yellow crystals, R_f = 0.10 (10% MeOH in CH₂Cl₂);¹H NMR (400 MHz, D₂O) δ (ppm): 8.25 (1H, d, J = 4.0 Hz), 7.74 (1H, dd, J = 8.0, 4.0 Hz), 7.26 (1H, d, J = 8.0 Hz), 4.23 (2H, s); ¹³C NMR (100 MHz, D₂O) δ (ppm): 153.8, 138.0, 127.4, 126.3, 125.1, 120.7, 42.0; FT-IR (ATR) (cm⁻¹): 2955, 1631, 1534, 1332, 1240.

Synthesis of (E)-8-Methyl-6-Nonenoic Acid (3)

Unsaturated fatty acid 3 was successfully synthesized via a Wittig reaction between an appropriate phosphonium salt and isobutyraldehyde, followed by Z-E isomerization with nitrous acid, according to a literature procedure.⁵³

Compound 3, clear oil, 24% yield, R_f = 0.64 (10% EtOAc in n-hexane): ¹H NMR (400 MHz, deuterated chloroform [CDCl₃]) δ (ppm): 5.42-5.30 (2H, m), 2.35 (2H, t, J = 7.6 Hz), 2.25-2.20 (1H, m), 2.02-1.97 (2 H, m), 1.67-1.60 (2H, m), 1.44-1.37 (2 H, m), 0.95 (6H, d, J = 6.8 Hz). ¹³C NMR (100 MHz, CDCl₃) δ (ppm): 180.6, 138.3, 126.5, 34.1, 32.2, 31.1, 29.1, 24.3, 22.8; FT-IR (ATR) (cm⁻¹): 2955, 1705, 968.

Synthesis of 8-Methylnonanoic Acid (4)

Saturated fatty acid 4 was readily prepared via the copper-catalyzed cross-coupling alkylation with a Grignard reagent and ethyl ω-haloalkylcarboxylate, followed by acid hydrolysis, as previously described.⁶³

Compound 4, clear oil, 19% yield, R_f = 0.64 (10% EtOAc in n-hexane): ¹H NMR (400 MHz, CDCl₃) δ (ppm): 2.35 (2H, t, J = 7.5 Hz), 1.65-1.59 (2H, m), 1.53-1.48 (1 H, m), 1.35-1.26 (6H, m), 1.18-1.14 (2 H, m), 0.86 (6H, d, J = 6.8 Hz). ¹³C NMR (100 MHz, CDCl₃) δ (ppm): 180.7, 39.1, 34.3, 29.6, 29.2, 28.1, 27.3, 24.8, 22.8; FT-IR (ATR) (cm⁻¹): 2924, 1705, 933.

Synthesis of (E)-N-(4-Hydroxy-3-Nitrobenzyl)-8-Methylnon-6-Enamide (5) and N-(4-Hydroxy-3-Nitrobenzyl)-8-Methylnonanamide (6)

EDC.HCl (0.73 mmol) and HOBt (0.73 mmol) were added to a solution of 3 (0.10 g, 0.61 mmol) or 4 (0.11 g, 0.61 mmol) in anhydrous N,N-dimethylformamide (DMF) (10.0 mL). The resulting mixture was stirred at 0 °C for 30 minutes and then allowed to warm up to room temperature. A mixture of 2 (0.15 g, 0.73 mmol) and triethylamine (0.16 mL, 1.2 mmol) in anhydrous DMF (5.0 mL) was added to the solution. The resulting mixture was stirred at room temperature under an N₂ atmosphere for 6 hours. Next, the reaction mixture was diluted with brine and extracted with ethyl acetate. The organic layer was washed with a citric acid solution (10% w/v), 0.5 M sodium bicarbonate, dried over anhydrous magnesium sulfate, and filtered. The organic layer was then concentrated and purified by flash column chromatography to give the desired products 5 (0.09 g, 47% yield) or 6 (0.10 g, 51% yield) from 3 and 4, respectively.

Compound 5, light yellow solid, R_f = 0.52 (30% EtOAc in n-hexane): ¹H NMR (400 MHz, CDCl₃) δ (ppm): 10.52 (1H, s), 7.98 (1H, d, J = 2.4 Hz), 7.53 (1H, dd, J = 8.8, 2.0 Hz), 7.12 (1H, d, J = 8.4 Hz), 5.91 (1H, br, NH), 5.36-5.31 (2H, m), 4.41 (2H, d, J = 6.0 Hz), 2.25-2.20 (3H, m), 2.01-1.96 (2 H, m), 1.69-1.62 (2H, m), 1.42-1.36 (2 H, m), 0.95 (6H, d, J = 6.8 Hz); ¹³C NMR (100 MHz, CDCl₃) δ (ppm): 173.3, 154.5, 138.3, 137.4, 131.4, 126.5, 123.7, 120.6, 42.3, 36.7, 32.3, 31.1, 29.4, 25.3, 22.8; FT-IR (ATR) (cm⁻¹): 3305, 1634, 1540, 1310; high resolution mass spectrometry (HRMS) (electrospray ionization-time-of-flight [ESI-TOF]) m/z 343.1612 [M + Na]⁺ (calcd for C₁₇H₂₄N₂O₄Na, 343.1628).

Compound 6, light yellow solid, R_f = 0.57 (30% EtOAc in n-hexane): ¹H NMR 400 MHz (CDCl₃) δ (ppm): 10.51 (1H, s), 7.98 (1H, d, J = 2.0 Hz), 7.53 (1H, dd, J = 8.8, 2.0 Hz), 7.12 (1H, d, J = 8.8 Hz), 5.94 (1H, br, NH), 4.44 (2H, d, J = 6.0 Hz), 2.23 (2H, t, J = 15.2 Hz), 1.70–1.63 (2H, m), 1.51–1.48 (1 H, m), 1.33-1.25 (6H, m), 1.16-1.13 (2 H, m), 0.94 (6H, d, J = 6.8 Hz); ¹³C NMR (CDCl₃, 100 MH_z)δ (ppm): 173.5, 154.5, 137.4, 131.4, 123.7, 120.6, 42.3, 39.1, 36.8, 29.7, 29.5, 28.1, 27.4, 25.8, 22.8; FT-IR (ATR) (cm⁻¹): 3310, 1647, 1542, 1316; HRMS (ESI-TOF) m/z 323.1978 [M + H]⁺ (calcd for C₁₇H₂₇N₂O₄, 323.1965).

Cell Culture and Differentiation

3T3-L1 Preadipocytes (ATCC CL-173) were cultured in DMEM supplemented with 3.7 g/L sodium bicarbonate, 10% BCS, and antibiotics at 37 °C in a humidified atmosphere of 5% CO₂. The medium was changed every 3 days. The cells were subcultured after reaching 80% confluence, seeded in a 96-well plate at a density of 2 × 10³ cells/well, and cultured in maintenance medium (DMEM containing 10% BCS and 1% antibiotics) until 90%-95% confluence. After reaching the desired confluence (defined as day 0), the cells were further induced with initiation medium (1 µM DEX, 0.5 mM IBMX, 10 µg/mL insulin in 10% FBS-DMEM) for 3 days. At the end of the third day, the initiation medium was replaced with the progression medium (10 µg/mL insulin in 10% FBS-DMEM). The media was changed every 2 days until day 9, and then the cells were differentiated into a rounded shape with lipid droplets. The morphology of mature adipocytes was examined using a microscope.

Cell Viability Assay

Cell viability was determined by the MTT assay to define a suitable concentration for all testing. Differentiated 3T3-L1 adipocytes were treated with 5, 10, 25, 50, and 100 µM CAP dissolved in DMSO for 24 hours in a humidified 5% carbon dioxide (CO₂) atmosphere at 37 °C. The final concentration of DMSO in the culture medium was 0.2 %v/v. The vehicle control contained the same concentration of DMSO, but no CAP. After incubation, MTT reagent in PBS solution was added to each well plate, and the plate was incubated for another 3 hours. Subsequently, the culture medium containing MTT reagent was removed. The formazan produced in the viable cells was dissolved by the addition of DMSO. The absorbance at 595 nm was measured using a microplate reader. The values were presented as a percentage of those for control cells without capsaicinoid and analogs. The effects of CAP, DHC, 5, and 6 on the viability of differentiated 3T3-L1 adipocytes were evaluated by treatment of the cells with 10 µM of each compound according to the above-mentioned procedure. All measurements were performed in at least 3 independent experiments, each of which was performed in triplicate (n = 3).

Determination of Lipid Accumulation in 3T3-L1 (Oil Red O Staining)

To examine the effects of CAP, DHC, 5, and 6 on lipid accumulation, serum-free DMEM was added to the microplate wells of the mature adipocytes, after which the cells were treated with 10 µM of CAP, DHC, 5, and 6 for 24 hours. The lipid droplets were then stained with Oil Red O.

Differentiated 3T3-L1 adipocytes were placed in a 96-well plate with CAP, DHC, 5, and 6. Following the treatment, the medium was removed from the plates, and the cells were rinsed twice with PBS to remove any remaining medium and fixed with 10% formaldehyde for 45 minutes at room temperature. Formaldehyde was then removed, and the cells were refixed with 10% formaldehyde for 1 hour at room temperature, and then washed with 60% isopropanol. A fresh Oil Red O solution (0.5% Oil Red O prepared in isopropanol: water, 3:2 v/v) was filtered through a 0.45-µm nylon filter, and 50 µL of the filtrate was added to each well of the well plate and left to stain the cells for 1 hour at room temperature. After staining, the cells were thoroughly rinsed with distilled water. The morphology of the stained cells was then examined using a microscope. The stained lipid droplets were then denatured and dissolved using isopropanol and mixed well until the dye was homogenously distributed in the isopropanol. The absorbance was measured at 500 nm using a microplate reader. Lipid accumulation measurements were performed in at least 3 independent experiments, each of which was performed in triplicate (N = 3). The values were expressed as a percentage of the result for control cells lacking capsaicinoid and analogs.

Triglyceride Assay

Differentiated 3T3-L1 adipocytes were treated with 10 µM of CAP, DHC, 5, and 6 in serum-free DMEM for 48 hours. The cells were collected by the addition of Triton X-100 (0.1% in 0.1 M sodium hydroxide). The cellular triglyceride content was determined using a triglyceride colorimetric assay kit (Cayman Chemical Co., USA), following the manufacturer’s protocols. Triglyceride levels were analyzed in at least 3 independent experiments, each of which was performed in triplicate (N = 3). The values were expressed as a percentage of triglycerides in the control without capsaicinoid and analogs.

Structure Preparations and Molecular Docking

In this study, the vanilloid binding site in the structure of the open TRPV1 channel in complex with RTX and DkTx (PDB ID: 3J5Q) was used as the target for docking of nitro capsaicin and CAP.⁶⁴ The -dimensional structure of this TRPV1 was retrieved from the Research Collaboratory for Structural Bioinformatics protein data bank. Before docking, the TRPV1 structure (chains B, D, E, and G) was cleaned up by removing double-knot toxin molecules (chains A, C, F, and H). The missing loop regions of the TRPV1 chains (503-LKSLF-507) were inserted based on the SEQRES data. The amino acid residues in TRPV1 were protonated at pH 7.4 according to the predicted pK values. The structure of TRPV1 was submitted for energy minimization with the conjugate gradient algorithms applying CHARMm forcefield with protein backbone constraints to reduce the atomic clash of amino acid side chains. The structures of 5 and CAP used as ligands for docking were retrieved from quantum mechanics optimization at the B3LYP/6-31+G(d) level of theory. The 20 Å binding site sphere in the TRPV1 channel was generated by using the center coordinate obtaining from the arithmetic mean coordinates of the residues Y511, M547, T550, E570, and L669 of chain D to cover the whole vanilloid binding pocket.⁶² The binding modes of 5 and CAP were predicted using the CDOCKER module⁶⁵ in Discovery Studio 2.5 software.⁶⁶ In CDOCKER, 100 random ligand conformations were generated in the vanilloid binding site of the TRPV1 structure. The temperature was set to 700 K for 2000 steps and cooled to 300 K for 5000 steps. The grid extension was set to 8 Å, and 10 ligand-binding poses were ranked according to their CDOCKER Energies scores (kcal/mol). The CDOCKER Interaction Energy scores (kcal/mol) of docking poses were recorded. After docking, the successful conformations were sorted from high to low according to their CDOCKER Interaction Energy score towards the TRPV1 target. The docking pose with the highest CDOCKER Interaction Energy score was selected as an active conformation for further analyses. The structures of complexes were submitted for energy minimization with CHARMm forcefield using the Steepest Descent (100 000 steps) followed by the Adopted Basis Newton Raphson (ABNR) algorithms (50 000 steps) to obtain the stable structure with a convergence criterion of 0.001 kcal/(mol×Å) energy RMS Gradient. Harmonic restraints were applied on the protein backbone during the minimization steps with 40 kcal/mol/Å⁻². The overall binding free energy of the obtained complex was estimated between ligands and target using CHARMm-based energies methods.⁶⁷ The nonbonded interactions (ie, van der Waals and electrostatic terms) between the ligand (5 and CAP) and each amino acid residue within 4 Å around the ligand were calculated using the CHARMm-based Interaction Energy protocol. All molecular modeling techniques and calculations were performed using the program Discovery Studio 2.5. The graphics visualization tool for viewing, analyzing protein, and modeling data were carried out using the free DS Visualizer 2020.⁶⁸

Statistical Analysis

The values are expressed as mean ± SE. Statistical analyses were performed using SPSS software version 17.0 (SPSS Inc, Chicago, IL, USA). Significant differences between groups were analyzed using a one-way analysis of variance followed by Tukey’s multiple comparison tests. A value of P < 0.05 indicated a significant difference.

Supplemental Material

Supplementary Material 1 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 1, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 2 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 2, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 3 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 3, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 4 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 4, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 5 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 5, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 6 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 6, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 7 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 7, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 8 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 8, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 9 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 9, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 10 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 10, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 11 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 11, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 12 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 12, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 13 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 13, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 14 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 14, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 15 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 15, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 16 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 16, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Supplemental Material

Supplementary Material 17 - Supplemental material for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs

Supplemental material, Supplementary Material 17, for Enhancement of Lipolysis in 3T3-L1 Adipocytes by Nitroarene Capsaicinoid Analogs by Thanet Laolob, Nuntavan Bunyapraphatsara, Neti Waranuch, Sutatip Pongcharoen, Wikorn Punyain, Sirirat Chancharunee, Krisada Sakchaisri, Jaturong Pratuangdejkul, Sumet Chongruchiroj, Filip Kielar and Uthai Wichai in Natural Product Communications

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Thailand Research Fund (RDG6020016).

ORCID iDs

Thanet Laolob

Uthai Wichai

Supplemental Material

Supplemental material for this article is available online.

References

World Health Organization . Obesity and overweight. Accessed March 31, 2019. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

World Health Organization . Noncommunicable diseases. Accessed May 01, 2019. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

Martyn

JAJ.

Kaneki

Yasuhara

. Obesity-Induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology. 2008;109(1):137-148.doi:10.1097/ALN.0b013e3181799d45

18580184

. Obesity-related hypertension. Ochsner J. 2009;9(3):133-136.21603428

Cho

Manson

JE.

Stampfer

et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care. 2002;25(7):1142-1148.doi:10.2337/diacare.25.7.1142

12087011

Kurth

Gaziano

JM.

Berger

et al. Body mass index and the risk of stroke in men. Arch Intern Med. 2002;162(22):2557-2562.doi:10.1001/archinte.162.22.2557

12456227

Rabec

de Lucas Ramos

Veale

. Respiratory complications of obesity. Arch Bronconeumol. 2011;47(5):252-261.doi:10.1016/j.arbres.2011.01.012

21458904

Angelo Carpi

. Obesity and increased risk for atherosclerosis and cancer. Internal Medicine: Open Access. 2014;4(3):1-8.

Flatt

J-P

. Differences in basal energy expenditure and obesity. Obesity. 2007;15(11):2546-2548.doi:10.1038/oby.2007.304

18070743

10.

Redinger

. Fat storage and the biology of energy expenditure. Transl Res. 2009;154(2):52-60.doi:10.1016/j.trsl.2009.05.003

19595436

11.

Choe

SS.

Huh

JY.

Hwang

IJ.

Kim

JI.

Kim

. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol. 2016;7(Suppl 2):1-16.doi:10.3389/fendo.2016.00030

27148161

12.

Shreif

Periwal

. Quantitative dynamics of adipose cells. Adipocyte. 2012;1(2):80-88.doi:10.4161/adip.19705

23700516

13.

Luo

Liu

. Adipose tissue in control of metabolism. J Endocrinol. 2016;231(3):R77-R99.doi:10.1530/JOE-16-0211

27935822

14.

Zechner

Zimmermann

Eichmann

et al. FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012;15(3):279-291.doi:10.1016/j.cmet.2011.12.018

22405066

15.

Lass

Zimmermann

Oberer

Zechner

. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res. 2011;50(1):14-27.doi:10.1016/j.plipres.2010.10.004

21087632

16.

Camp

HS.

Ren

Leff

. Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol Med. 2002;8(9):442-447.doi:10.1016/S1471-4914(02)02396-1

12223316

17.

Ntambi

JM.

Young-Cheul

. Adipocyte differentiation and gene expression. J Nutr. 2000;130(12):3122S-3126.doi:10.1093/jn/130.12.3122S

11110885

18.

Sun

Kusminski

CM.

Scherer

. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094-2101.doi:10.1172/JCI45887

21633177

19.

Mohamed

GA.

Ibrahim

SRM.

Elkhayat

ES.

El Dine

. Natural anti-obesity agents. Bulletin of Faculty of Pharmacy, Cairo University. 2014;52(2):269-284.doi:10.1016/j.bfopcu.2014.05.001

20.

Aguirre

Fernández-Quintela

Arias

Portillo

. Resveratrol: anti-obesity mechanisms of action. Molecules. 2014;19(11):18632-18655.doi:10.3390/molecules191118632

25405284

21.

Bae

C-R.

Park

Y-K.

Cha

Y-S

. Quercetin-rich onion peel extract suppresses adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 adipocytes. J Sci Food Agric. 2014;94(13):2655-2660.doi:10.1002/jsfa.6604

24634340

22.

Behloul

. Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol. 2013;698(1-3):31-38.doi:10.1016/j.ejphar.2012.11.013

23178528

23.

Suk

Seo

SG.

et al. A bioactive constituent of ginger, 6-shogaol, prevents adipogenesis and stimulates lipolysis in 3T3-L1 adipocytes. J Food Biochem. 2016;40(1):84-90.doi:10.1111/jfbc.12191

24.

Park

U-H.

Jeong

H-S.

E-Y

et al. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells. J Agric Food Chem. 2012;60(15):3853-3860.doi:10.1021/jf204514a

22463744

25.

Varghese

Kubatka

Rodrigo

et al. Chili pepper as a body weight-loss food. Int J Food Sci Nutr. 2017;68(4):392-401.doi:10.1080/09637486.2016.1258044

27899046

26.

Sun

Xiong

Zhu

. Dietary capsaicin protects cardiometabolic organs from dysfunction. Nutrients. 2016;8(5):174-13.doi:10.3390/nu8050174

27120617

27.

Aniwan

Gonlachanvit

. Effects of chili treatment on gastrointestinal and rectal sensation in diarrhea-predominant irritable bowel syndrome: a randomized, double-blinded, crossover study. J Neurogastroenterol Motil. 2014;20(3):400-406.doi:10.5056/jnm14022

24867591

28.

Chen

Huang

et al. Capsaicin attenuates amyloid-β-induced synapse loss and cognitive impairments in mice. J Alzheimers Dis. 2017;59(2):683-694.doi:10.3233/JAD-170337

28671132

29.

Clark

Lee

S-H

. Anticancer properties of capsaicin against human cancer. Anticancer Res. 2016;36(3):837-843.26976969

30.

Engler

Aeschlimann

Simmen

et al. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun. 2007;359(4):884-888.doi:10.1016/j.bbrc.2007.05.178

17560936

31.

Yang

Xiao

Cheng

et al. Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel. Nat Chem Biol. 2015;11(7):518-524.doi:10.1038/nchembio.1835

26053297

32.

Chen

et al. Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated ^Ca2+ influx. Cardiovasc Diabetol. 2015;14(1):14-22.doi:10.1186/s12933-015-0183-6

25849380

33.

Walpole

CS.

Wrigglesworth

Bevan

et al. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic “A-region”. J Med Chem. 1993;36(16):2362-2372.doi:10.1021/jm00068a014

8360881

34.

Thomas

KC.

Ethirajan

Shahrokh

et al. Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity. J Pharmacol Exp Ther. 2011;337(2):400-410.doi:10.1124/jpet.110.178491

21343315

35.

Nie

Qiao

et al. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists. Eur J Med Chem. 2019;178:433-445.doi:10.1016/j.ejmech.2019.06.007

31202991

36.

Fattori

Hohmann

MSN.

Rossaneis

AC.

Pinho-Ribeiro

FA.

Verri

. Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules. 2016;21(7):844-33.doi:10.3390/molecules21070844

27367653

37.

McDonald

HA.

Neelands

TR.

Kort

et al. Characterization of A-425619 at native TRPV1 receptors: a comparison between dorsal root ganglia and trigeminal ganglia. Eur J Pharmacol. 2008;596(1-3):62-69.doi:10.1016/j.ejphar.2008.07.063

18755179

38.

Pomonis

JD.

Harrison

JE.

Mark

Bristol

DR.

Valenzano

KJ.

Walker

. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2003;306(1):387-393.doi:10.1124/jpet.102.046268

12721336

39.

Surowy

CS.

Neelands

TR.

Bianchi

et al. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo. J Pharmacol Exp Ther. 2008;326(3):879-888.doi:10.1124/jpet.108.138511

18515644

40.

Walpole

CSJ.

Wrigglesworth

Bevan

et al. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond “B-region”. J Med Chem. 1993;36(16):2373-2380.doi:10.1021/jm00068a015

8360882

41.

Walpole

CS.

Bevan

Bloomfield

et al. Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues. J Med Chem. 1996;39(15):2939-2952.doi:10.1021/jm960139d

8709128

42.

Lee

Kang

S-U.

Choi

H-K

et al. Analysis of structure-activity relationships for the ‘B-region’ of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity. Bioorg Med Chem Lett. 2004;14(9):2291-2297.doi:10.1016/j.bmcl.2004.02.002

15081027

43.

Sun

Liu

Ryu

et al. 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure-activity relationships in the B and C-regions. Bioorg Med Chem. 2012;20(3):1310-1318.doi:10.1016/j.bmc.2011.12.014

22227463

44.

Walpole

CS.

Wrigglesworth

Bevan

et al. Analogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain “C-region”. J Med Chem. 1993;36(16):2381-2389.doi:10.1021/jm00068a016

8360883

45.

Barbero

GF.

Molinillo

JMG.

Varela

RM.

Palma

Macías

FA.

Barroso

. Application of Hansch's model to capsaicinoids and capsinoids: a study using the quantitative structure-activity relationship. A novel method for the synthesis of capsinoids. J Agric Food Chem. 2010;58(6):3342-3349.doi:10.1021/jf9035029

20178388

46.

Appendino

De Petrocellis

Trevisani

et al. Development of the first ultra-potent “capsaicinoid” agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. J Pharmacol Exp Ther. 2005;312(2):561-570.doi:10.1124/jpet.104.074864

15356216

47.

Basith

Cui

Hong

Choi

. Harnessing the therapeutic potential of capsaicin and its analogues in pain and other diseases. Molecules. 2016;21(8):966-28.doi:10.3390/molecules21080966

27455231

48.

Chen

Liu

. π–π stacking interaction: a nondestructive and facile means in material engineering for bioapplications. Cryst Growth Des. 2018;18(5):2765-2783.doi:10.1021/acs.cgd.7b01503

49.

Bloom

JWG.

Wheeler

. Quantifying the π-stacking interactions in nitroarene binding sites of proteins. J Phys Chem B. 2015;119(45):14441-14450.doi:10.1021/acs.jpcb.5b08126

26491883

50.

Wrigglesworth

Walpole

CS.

Bevan

et al. Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. potent, orally active analgesics. J Med Chem. 1996;39(25):4942-4951.doi:10.1021/jm960512h

8960554

51.

Aza-González

Núñez-Palenius

HG.

Ochoa-Alejo

. Molecular biology of capsaicinoid biosynthesis in chili pepper (Capsicum spp.. Plant Cell Rep. 2011;30(5):695-706.doi:10.1007/s00299-010-0968-8

21161234

52.

Kobata

Kawaguchi

Watanabe

. Enzymatic synthesis of a capsinoid by the acylation of vanillyl alcohol with fatty acid derivatives catalyzed by lipases. Biosci Biotechnol Biochem. 2002;66(2):319-327.doi:10.1271/bbb.66.319

11999404

53.

Kaga

Miura

Orito

. A facile procedure for synthesis of capsaicin. J Org Chem. 1989;54(14):3477-3478.doi:10.1021/jo00275a040

54.

Ingersoll

. α-Phenylethylamine. Org. Synth. 1937;17(76):1-5.

55.

Berkoz

Yildirim

Arvas

Turkmen

Allahverdiyev

. Effect of capsaicin on transcription factors in 3T3-L1 cell line. East J Med. 2015;20(1):34-35.

56.

Guckian

KM.

Schweitzer

BA.

Ren

RX-F.

Sheils

CJ.

Tahmassebi

DC.

Kool

. Factors contributing to aromatic stacking in water: evaluation in the context of DNA. J Am Chem Soc. 2000;122(10):2213-2222.doi:10.1021/ja9934854

20865137

57.

Bauzá

Frontera

Mooibroek

. π-Hole interactions involving nitro aromatic ligands in protein structures. Chemistry. 2019;25(58):13436-13443.doi:10.1002/chem.201903404

31453653

58.

Frisch

MJ.

Trucks

GW.

Schlegel

et al. Gaussian 09, Revision D.01. Gaussian, Inc. Wallingford CT; 2009.

59.

Allouche

A-R

. Gabedit--a graphical user interface for computational chemistry softwares. J Comput Chem. 2011;32(1):174-182.doi:10.1002/jcc.21600

20607691

60.

Darré

Domene

. Binding of capsaicin to the TRPV1 ion channel. Mol Pharm. 2015;12(12):4454-4465.doi:10.1021/acs.molpharmaceut.5b00641

26502196

61.

Poblete

Oyarzún

Olivero

et al. Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) binding to transient receptor potential V1 (TRPV1) channels. J Biol Chem. 2015;290(4):2086-2098.doi:10.1074/jbc.M114.613620

25425643

62.

Duarte

Cáceres

Sepúlveda

et al. Novel TRPV1 channel agonists with faster and more potent analgesic properties than capsaicin. Front Pharmacol. 2020;11(1040):1-14.doi:10.3389/fphar.2020.01040

63.

Kurosawa

Nakano

Amino

. Practical large-scale production of dihydrocapsiate, a nonpungent capsaicinoid-like substance. Biosci Biotechnol Biochem. 2017;81(2):211-221.doi:10.1080/09168451.2016.1254533

27838955

64.

Liao

Cao

Julius

Cheng

. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature. 2013;504(7478):107-112.doi:10.1038/nature12822

24305160

65.

Robertson

DH.

Brooks

CL.

Vieth

. Detailed analysis of GRID-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem. 2003;24(13):1549-1562.doi:10.1002/jcc.10306

12925999

66.

Discovery Studio 2.5, Accelrys, Inc., San Diego, CA, USA . 2010

67.

Tirado-Rives

Jorgensen

WL.

Julian Tirado-Rives

WLJ

. Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. J Med Chem. 2006;49(20):5880-5884.doi:10.1021/jm060763i

17004703

68.

BIOVIA . Discovery Visualizer (v.20.1.0.19295). San Diego; 2020.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.18 MB

0.54 MB

0.33 MB

0.45 MB

0.47 MB

0.52 MB

0.36 MB

0.43 MB

0.50 MB

0.37 MB

0.54 MB

0.42 MB

0.26 MB

0.33 MB

0.37 MB

0.26 MB

0.34 MB